Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Neurocrine adds a Parkinson’s drug to its late-stage pipeline in $145M deal
Neurocrine adds a Parkinson’s drug to its late-stage pipeline in $145M deal
Neurocrine adds a Parkinson’s drug to its late-stage pipeline in $145M deal
Submitted by
admin
on February 9, 2017 - 9:24pm
Source:
Endpoints
News Tags:
Neurocrine
Parkinson's Disease
Ongentys
Bial
Headline:
Neurocrine adds a Parkinson’s drug to its late-stage pipeline in $145M deal
Do Not Allow Advertisers to Use My Personal information
